← Back to headlines
Anti-Amyloid Antibodies Show Little Effect on Alzheimer's Cognitive Function
A Cochrane review of monoclonal antibodies targeting amyloid plaques in Alzheimer's Disease has concluded that these drugs have little to no effect on the cognitive function of patients, indicating the disease remains a mystery.
24 Apr, 18:00 — 24 Apr, 18:00


